Cover image of the article: the Association between Acute Myocardial Infarction and Anti Helicobacter Pylori Antibody

Image Credit:Zahedan J Res Med Sci

the Association between Acute Myocardial Infarction and Anti Helicobacter Pylori Antibody

Authors

Fariba Raygan1, Hamid Khorasanifar2, Mansoure Momen heravi3,*, Abbas Arj1, Hossein Akbari4
1Assistant Prof, Dept of Internal Medicine, Faculty of Medicine, Kashan University of Medical Sciences and Health Services, Kashan, Iran.
2Internist, Fellow of Geriatrics, Mayo Clinic of USA
3Assistant Prof, Dept of Infectious Disease, Kashan University of Medical Sciences and Health Services, Kashan, Iran.
4Instructor, Dept of Biostatics, Faculty of Public Health, Kashan University of Medical Sciences and Health Services, Kashan, Iran
*Corresponding Author: Assistant Prof, Dept of Infectious Disease, Kashan University of Medical Sciences and Health Services, Kashan, Iran. Email: mansoreheravi@yahoo.com

Zahedan Journal of Research in Medical Sciences:Vol. 11, issue 2; e94400
Published online:Jul 26, 2009
Article type:Research Article
Received:Jun 20, 2008
Accepted:May 09, 2009
How to Cite:Raygan F, Khorasanifar H, Momen heravi M, Arj A, Akbari H. the Association between Acute Myocardial Infarction and Anti Helicobacter Pylori Antibody. Zahedan J Res Med Sci. 2009;11(2):e94400. doi:

Abstract

Background: Myocardial infarction (MI) is one of the most common causes of hospitalization of
patients in western countries. Recently, the role of infectious factors such as Helicobacter pylori as
a risk factor for cardiovascular disease has been suggested. This study was conducted to determine
whether previous exposure to H. pylori is associated with an increased risk for myocardial
infarction.
Materials and Methods: This case-control study was performed on 100 hospitalized patients (50
cases and 50 controls) in Shahid Beheshti hospital of Kashan in 2006. Three milliliter blood was
obtained from each of 50 survivors of acute myocardial infarction (case) and 50 controls with no
history of coronary heart disease and then Anti H. pylori antibody was examined by ELISA. Using
chi-square and Fisher exact test the results were analyzed and P value less then 0.05 was
considered significant.
Results: Nine patients (18%) were seronegative, 5(10%) borderline and 36(72%) seropositive for
Anti-H.plyori antibodies in case group, where as in controls these proportions were 14(28%),
10(20%) and 26(52%), respectively. No significant association was noted between H pylori
seropositivity and risk of MI (P value=0.11).The mean of titer of antibody was 22.6 ±19.8 in
controls and 35.9±31.8 in cases and there was significant correlation between them (P
value<0.001).
Conclusion: This study revealed no association between MI and H. pylori seropositivity. To show
a causal association, very large randomized trials would be needed.

Highlights

Fulltext

The full text of this article is available on the PDF file.

References

  • 1.
    The References of this article are available on the PDF file.

Copyright

© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Jun
2012
Coexistence of gastric Helicobacter pylori infection and coronary artery diseases in Qazvin (Iran)

Coexistence of gastric Helicobacter pylori infection and coronary artery diseases in Qazvin (Iran)

S Sayyah,
M Akbarian,
S AbdollahSalimi,
M Tavakoli,
Pahlevan AA

Sayyah S, Akbarian M, AbdollahSalimi S, Tavakoli M, AA P. Coexistence of gastric Helicobacter pylori infection and coronary artery diseases in Qazvin (Iran). J Inflamm Dis. 2024;16(1):e155679. doi:

26
Oct
2004
The comparison of titer of Helicobacter Pylori antibody in patients with gastric carcinoma and control group in Zahedan

The comparison of titer of Helicobacter Pylori antibody in patients with gastric carcinoma and control group in Zahedan

SK Nezam,
H Rahimi

Nezam S, Rahimi H. The comparison of titer of Helicobacter Pylori antibody in patients with gastric carcinoma and control group in Zahedan. Zahedan J Res Med Sci. 2005;7(4):e94922. doi:

31
Jan
2010
Seroprevalence study of Helicobacter pylori infection among visitors of cardiac patients in Razi hospital in Ahvaz, Iran

Seroprevalence study of Helicobacter pylori infection among visitors of cardiac patients in Razi hospital in Ahvaz, Iran

Seyed Mohammad Alavi,
Seyed Mohammad Hasan Adel,
Alireza Rajabzadeh

Alavi SM, Adel SMH, Rajabzadeh A. Seroprevalence study of Helicobacter pylori infection among visitors of cardiac patients in Razi hospital in Ahvaz, Iran. Jundishapur J Microbiol. 2010;3(1):. doi:

20
Jun
2009
Seroprevalence of Chlamydia pneumonia in patients with myocardial infarction

Seroprevalence of Chlamydia pneumonia in patients with myocardial infarction

Hamidreza Honarmand,
Mehdi Hajian,
Morteza Rahbar-Taramsari,
Ebrahim Mirzajani

Honarmand H, Hajian M, Rahbar-Taramsari M, Mirzajani E. Seroprevalence of Chlamydia pneumonia in patients with myocardial infarction. koomesh. 2009;10(4):e153796. doi:

6
Aug
2023
Serum Evaluation of Helicobacter pylori in Patients with Multiple Sclerosis

Serum Evaluation of Helicobacter pylori in Patients with Multiple Sclerosis

Mojtaba Meshkat,
Yeganeh Behjati,
Mansooreh Bakhshi,
Zahra Meshkat,
Mina Yazdan Mehr,
Reza Boostani
,et al.

Meshkat M, Behjati Y, Bakhshi M, Meshkat Z, Yazdan Mehr M, et al. Serum Evaluation of Helicobacter pylori in Patients with Multiple Sclerosis. Arch Neurosci. 2023;10(3):e133607. doi: https://doi.org/10.5812/ans-133607

More by these authors

Fariba RayganPubMedScholar
Hamid KhorasanifarPubMedScholar
Mansoure Momen heraviPubMedScholar
Abbas ArjPubMedScholar
Hossein AkbariPubMedScholar
Share
Cited by
Metrics